Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetics, safety, and antiviral activity of JNJ-63623872 in combination with oseltamivir for adults and elderly hospitalized wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Infection

Drugs mentioned

• JNJ-63623872
• OSELTAMIVIR (oseltamivir phosphate)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Influenza A Virus | Phase 2 | Status: COMPLETED | Results posted: 2020-03-27